Phase II and UGT1A1 polymorphism study of two different irinotecan dosages combined with cisplatin as first-line therapy for advanced gastric cancer

Chemotherapy

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/1S5VBUB
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1T3eav8
via IFTTT